Milford, MA, United States of America

Dennis J Nilan

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dennis J Nilan: Innovator in Amyloid Protein Detection

Introduction

Dennis J Nilan is a notable inventor based in Milford, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of amyloid proteins. With a total of 3 patents to his name, Nilan's work is paving the way for advancements in understanding amyloidogenic disorders.

Latest Patents

One of Nilan's latest patents is a system and method for detecting amyloid proteins. This invention provides a device and method for detecting an amyloid protein in the eye of a mammal. The method involves illuminating the eye with a light source that has specific wavelength and polarization properties. This illumination produces fluorescence in an amyloid-binding compound when it is bound to the amyloid protein. The compound is introduced to the eye and specifically binds to the amyloid protein, which is indicative of an amyloidogenic disorder. The method also includes determining a time decay rate of fluorescence, allowing for the distinction of the presence of the amyloid-binding compound in the eye based on this rate.

Career Highlights

Dennis J Nilan is currently associated with Cognoptix, Inc., where he continues to innovate in the field of medical technology. His work focuses on developing methods that enhance the detection of amyloid proteins, which are crucial in diagnosing various neurodegenerative diseases.

Collaborations

Nilan collaborates with esteemed colleagues such as Paul D Hartung and Vincent Valvo. Their combined expertise contributes to the advancement of technologies aimed at improving patient outcomes in the realm of amyloid-related disorders.

Conclusion

Dennis J Nilan's contributions to the detection of amyloid proteins represent a significant advancement in medical diagnostics. His innovative work at Cognoptix, Inc. continues to influence the field and offers hope for better diagnostic methods in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…